Childhood pneumonia - Preventing the world's biggest killer of children

Bulletin of the World Health Organization

Volumn 85, Issue 7, 2007, Pages 502-503

  Greenwood, Brian M ^a   Weber, Martin W ^b   Mulholland, Kim ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; PNEUMOCOCCUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AWARENESS; CHILD DEATH; CHILDHOOD DISEASE; DEVELOPING COUNTRY; DIARRHEA; DISEASE CONTROL; EDITORIAL; FINANCIAL MANAGEMENT; HEALTH CARE; HUMAN; IMMUNIZATION; MALARIA; MATERNAL MORTALITY; PNEUMONIA; TUBERCULOSIS; VACCINATION; WORLD HEALTH ORGANIZATION;

CHILD; CHILD HEALTH SERVICES; DIET; ENVIRONMENTAL HEALTH; HAEMOPHILUS VACCINES; HUMANS; MATERNAL HEALTH SERVICES; PNEUMOCOCCAL VACCINES; PNEUMONIA; PNEUMONIA, BACTERIAL; UNITED NATIONS; WORLD HEALTH;

EID: 34447257369     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.07.044032     Document Type: Editorial

References (12)

1. Bryce J, Boschi-Pinto C, Shibuya K, Black RE. WHO estimates of the causes of death in children. Lancet 2005;365:1147-52.
2. Cutts FT, Zaman SMA, Enwere G, Jaffar S, Levine OS, Okoko JB, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in the Gambia: randomised, double-blind, placebo-controlled trial. Lancet 2005;365:1139-46.
3. Gessner BD, Sutanto A, Linehan M, Djelantik IGG, Fletcher T, Gerudug IK, et al. Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe. Lancet 2005;365:43-52.
4. Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003;349:1341-8.
5. Mulholland K, Hilton S, Adegbola R, Usen S, Oparaugo A, Omosigho C, et al. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine for prevention of pneumonia and meningitis in Gambian infants. Lancet 1997;349:1191-7.
6. Pakistan Multicentre Amoxicillin Short Course Therapy (MASCOT) Study Group. Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial. Lancet 2002;360:835-41.
7. Addo-Yobo E, Chisaka N, Hassan M, Hibberd P, Lozano JM, Jeena P, et al. Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study. Lancet 2004;364:1141-8.
8. Agarwal G, Awasthi S, Kabra SK, Kaul A, Singhi S, Walter SD, et al. Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial. BMJ 2004;328:791-4.
9. Straus WL, Qazi SA, Kundi Z, Nomani NK, Schwartz B. Antimicrobial resistance and clinical effectiveness of co-trimoxazole versus amoxycillin for pneumonia among children in Pakistan: randomised controlled trial. Lancet 1998;352:270-4.
10. IMCI chart booklet. Geneva: WHO, 1995. Available at: http://www.who.int/child-adolescent-health/New_Publications/IMCI/Chartbooklet. pdf
11. Powell-Jackson T, Borghi J, Mueller DH, Patouillard E, Mills A. Countdown to 2015: tracking donor assistance to maternal, newborn, and child health. Lancet 2006;368:1077-87.
12. Pneumonia, the forgotten killer of children. Geneva: UNICEF/ WHO; 2006. Available at: http://whqlibdoc.who.int/publications/2006/9280640489_eng. pdf